NEWS IN BRIEF
Eusa Pharma focuses on biopharma with two strategic moves
Eusa Pharma has completed the acquisition of global rights for J&J’s Sylvant, shortly after selling its critical care business to Serb Pharmaceuticals.
Archives for July 25, 2018
CAR-T concerns for Novartis as Kymriah identified out of spec
Novartis is working with the US FDA to solve a manufacturing issue affecting Kymriah, identified as ‘variability in its commercial specifications’, says CEO.
PTC to acquire Agilis Biotherapeutics advancing its commitment to gene therapy
PTC Therapeutics will acquire Agilis Biotherapeutics to continue work on gene therapy for rare monogenic diseases affecting the central nervous system.
TxCell CEO says acquisition by Sangamo a ‘perfect fit’
TxCell confirmed that it has accepted a €72m offer from Sangamo in a deal that will be completed by the end of the year.